نتایج جستجو برای: 90 y

تعداد نتایج: 699350  

Journal: :journal of minimally invasive surgical sciences 0
abdolreza pazouki abdolreza pazouki, minimally invasive surgery research center, hazrat rasoul medical center, faculty of medicine, tehran university of medical sciences, tehran, ir iran ali jangjoo surgical oncology research center, imam reza hospital, faculty of medicine, mashhad university of medical sciences, mashhad, ir iran; surgical oncology research center, imam reza hospital, faculty of medicine, mashhad university of medical sciences, mashhad, ir iran. tel: +98-5118022664, fax: +98-5118525255 mohammad ali pakaneh abdolreza pazouki, minimally invasive surgery research center, hazrat rasoul medical center, faculty of medicine, tehran university of medical sciences, tehran, ir iran

abstract bowel obstruction is a known complication after bariatric surgery especially roux-en-y gastric bypass. the known etiologies include internal hernia, jejunojejunostomy stricture, ileus, intussusceptions, superior mesenteric artery syndrome, incarcerated port site hernia, and adhesions. blood clot is a rare cause of small intestinal obstruction after laparoscopic roux-en-y gastric bypass...

2014
David L Bushnell Mark T Madsen Thomas O’cdorisio Yusuf Menda Saima Muzahir Randi Ryan M Sue O’dorisio

BACKGROUND Peptide receptor radionuclide therapy (PRRT) is an effective form of treatment for patients with metastatic neuroendocrine tumors (NETs). However, delivering sufficient radiation dose to the tumor to result in a high percentage of long-term tumor remissions remains challenging because of the limits imposed on administered activity levels by radiation damage to normal tissues. The goa...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016
Ryan Hickey Robert J Lewandowski Totianna Prudhomme Eduardo Ehrenwald Brian Baigorri Jeffrey Critchfield Joseph Kallini Ahmed Gabr Boris Gorodetski Jean-Francois Geschwind Andrea Abbott Ravi Shridhar Sarah B White William S Rilling Brendan Boyer Shannon Kauffman Sharon Kwan Siddarth A Padia Vanessa L Gates Mary Mulcahy Sheetal Kircher Halla Nimeiri Al B Benson Riad Salem

UNLABELLED Hepatic metastases of colorectal carcinoma are a leading cause of cancer-related mortality. Most colorectal liver metastases become refractory to chemotherapy and biologic agents, at which point the median overall survival declines to 4-5 mo. Radioembolization with (90)Y has been used in the salvage setting with favorable outcomes. This study reports the survival and safety outcomes ...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2015
Karine Gerster-Gilliéron Flavio Forrer Helmut Maecke Jan Mueller-Brand Adrian Merlo Dominik Cordier

UNLABELLED The standard treatment of meningiomas is surgery or radiotherapy. Complex, especially recurrent or progressive cases, may exhibit tumor growth involving critical neurovascular structures or diffuse growth, resulting in limited efficacy and higher risk of standard treatment. We evaluated whether somatostatin receptor-targeted radionuclide therapy with (90)Y-DOTATOC may be a therapeuti...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004
Jeffry A Siegel Brian E Zimmerman Kory Kodimer Mary A Dell William E Simon

UNLABELLED This investigation examined the accuracy of dose calibrator activity measurement of the beta-emitting radiopharmaceutical (90)Y-ibritumomab tiuxetan. METHODS Five different facilities independently measured (90)Y in a 10-mL syringe geometry with 30 dose calibrator models from 3 different manufacturers. The activities ranged from 81.4 MBq (2.2 mCi) to 1,406 MBq (38 mCi) over the vol...

ژورنال: :روانپزشکی و روانشناسی بالینی ایران 0
سپیده راجزی اصفهانی sepideh rajezi esfahani madani st, emam hosein hospital, tehran, iran, ir. fax: +9821-77553074تهران، خیابان شهید مدنی، بیمارستان امام حسین (ع). دورنگار: 77553074-021 یاسمن متقی پور yasaman motaghipour of shahid beheshti university of medical sciencesدانشگاه علوم پزشکی و خدمات بهداشتی درمانی شهید بهشتی کامبیز کامکاری kambiz kamkari islamic azad university of islamshahr دانشگاه آزاد اسلامی، واحد اسلامشهر علی رضا ظهیرالدین alireza zahiredin of shahid beheshti university of medical sciences, behavioral sciences research center of shahid beheshti university of medical sciencesدانشگاه علوم پزشکی شهید بهشتی، مرکز تحقیقات علوم رفتاری دانشگاه علوم پزشکی شهید بهشتی مسعود جان بزرگی masuod janbozorgi research institute of hawzah & university. پژوهشگاه حوزه و دانشگاه

هدف: هدف پژوهش حاضر، بررسی پایایی و روایی نسخه فارسی مقیاس وسواسی- اجباری ییل- براون (y-bocs) بود. روش: 140 بیمار مبتلا به اختلال وسواسی- اجباری (ocd)، به­عنوان گروه آزمایش و 30 فرد سالم، به­عنوان گروه گواه، به­صورت در دسترس انتخاب شدند. برای گردآوری داده­ها، افزون بر y-bocs، مصاحبه بالینی ساختاریافته برای اختلال­های محور i در dsm-iv (scid-i) و خرده­مقیاس وسواسی- اجباری سیاهه 90 گویه­ای نشانه­ه...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Eneida R Nemecek Donald K Hamlin Darrell R Fisher Kenneth A Krohn John M Pagel Frederick R Appelbaum Oliver W Press Dana C Matthews

PURPOSE Radioimmunotherapy may improve the outcome of hematopoietic cell transplantation for hematologic malignancies by delivering targeted radiation to hematopoietic organs while relatively sparing nontarget organs. We evaluated the organ localization of yttrium-90-labeled anti-CD45 ((90)Y-anti-CD45) antibody in macaques, a model that had previously predicted iodine-131-labeled anti-CD45 ((13...

Journal: :Cancer research 2008
Robert M Sharkey Habibe Karacay Samuel Litwin Edmund A Rossi William J McBride Chien-Hsing Chang David M Goldenberg

We examined whether a pretargeting method using a new recombinant anti-CD20 bispecific antibody (bsMAb) followed by (90)Y-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid ((90)Y-DOTA)-peptide could reduce hematologic toxicity yet improve therapeutic responses compared with conventional (90)Y-anti-CD20 IgG and a chemically conjugated bsMAb. TF4, a humanized, tri-Fab bsMAb with two F...

2009
Christos Emmanouilides

Several studies have indicated that radioimmunotherapy is an effective and clinically relevant complementary therapeutic approach for patients with B-cell non-Hodgkin's lymphoma (NHL) and may convert partial to complete response when given as consolidation after induction chemotherapy. Yttrium-90((90)Y)-ibritumomab tiuxetan ((90)Y-IT, Zevalin(®), Y2B8) has documented efficacy for both indolent ...

Journal: :International journal of radiation oncology, biology, physics 2012
Wan-Yee Lau Andrew S Kennedy Yun Hwan Kim Hee Kit Lai Rheun-Chuan Lee Thomas W T Leung Ching-Sheng Liu Riad Salem Bruno Sangro Borys Shuter Shih-Chang Wang

PURPOSE Selective internal radiotherapy (SIRT) with yttrium-90 ((90)Y) resin microspheres can improve the clinical outcomes for selected patients with inoperable liver cancer. This technique involves intra-arterial delivery of β-emitting microspheres into hepatocellular carcinomas or liver metastases while sparing uninvolved structures. Its unique mode of action, including both (90)Y brachyther...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید